|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: RIBOZYME PHARMACEUTICALS INC, 10-Q, EX-10.2, 2000-08-14 |
Next: ACTION PERFORMANCE COMPANIES INC, 10-Q, 2000-08-14 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF RIBOZYME PHARMACEUTICALS, INC. FOR THE SIX MONTHS ENDED
JUNE 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 59,530,028
<SECURITIES> 4,050,476
<RECEIVABLES> 3,793,681
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 67,854,497
<PP&E> 12,575,930
<DEPRECIATION> 9,257,954
<TOTAL-ASSETS> 84,643,110
<CURRENT-LIABILITIES> 1,675,065
<BONDS> 0
0
120
<COMMON> 152,851
<OTHER-SE> 81,815,070
<TOTAL-LIABILITY-AND-EQUITY> 84,643,110
<SALES> 0
<TOTAL-REVENUES> 7,750,835
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 9,240,987
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 91,108
<INCOME-PRETAX> (6,274,800)
<INCOME-TAX> 0
<INCOME-CONTINUING> (6,274,800)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (6,274,800)
<EPS-BASIC> (0.47)
<EPS-DILUTED> (0.47)
</TABLE>
|
|